- Home
- ANEB vs FRD Comparison
ANEB vs FRD Comparison
Compare ANEB & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- FRD
- Stock Information
- Founded
- ANEB 2020
- FRD 1965
- Country
- ANEB United States
- FRD United States
- Employees
- ANEB N/A
- FRD N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- FRD Steel/Iron Ore
- Sector
- ANEB Health Care
- FRD Industrials
- Exchange
- ANEB Nasdaq
- FRD Nasdaq
- Market Cap
- ANEB 111.8M
- FRD 114.4M
- IPO Year
- ANEB 2021
- FRD N/A
- Fundamental
- Price
- ANEB $2.76
- FRD $22.06
- Analyst Decision
- ANEB Buy
- FRD
- Analyst Count
- ANEB 2
- FRD 0
- Target Price
- ANEB $8.00
- FRD N/A
- AVG Volume (30 Days)
- ANEB 25.7K
- FRD 14.7K
- Earning Date
- ANEB 11-12-2025
- FRD 11-11-2025
- Dividend Yield
- ANEB N/A
- FRD 0.75%
- EPS Growth
- ANEB N/A
- FRD N/A
- EPS
- ANEB N/A
- FRD 1.21
- Revenue
- ANEB N/A
- FRD $464,826,000.00
- Revenue This Year
- ANEB N/A
- FRD N/A
- Revenue Next Year
- ANEB N/A
- FRD N/A
- P/E Ratio
- ANEB N/A
- FRD $17.53
- Revenue Growth
- ANEB N/A
- FRD N/A
- 52 Week Low
- ANEB $0.80
- FRD $12.24
- 52 Week High
- ANEB $3.42
- FRD $22.98
- Technical
- Relative Strength Index (RSI)
- ANEB 64.17
- FRD 57.08
- Support Level
- ANEB $2.50
- FRD $19.53
- Resistance Level
- ANEB $2.76
- FRD $20.95
- Average True Range (ATR)
- ANEB 0.12
- FRD 0.69
- MACD
- ANEB 0.03
- FRD -0.00
- Stochastic Oscillator
- ANEB 85.00
- FRD 97.04
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.